| Johnson & Johnson: 72%, aber nur 57% gegen Mutante |  |
Johnson & Johnson’s Vaccine Offers Strong Protection but Fuels Concern About Variants
The vaccine’s efficacy rate dropped from 72 percent in the United States to just 57 percent in South Africa, where a highly contagious variant is driving most cases.
[https://www.nytimes.com/2021/01/29/health/covid-vaccine-johnson-and-johnson-variants.html]
Schön dass die EU so breit gestreut hat, aber alles in unzureichenden Mengen. Die Strategie war Mist und bleibt es auch....
gesendet mit m!client für iOS